China Health Technology Group proposes HKD 51.5 million rights issue; shares offered at HKD 0.25 each

Reuters03-27
<a href="https://laohu8.com/S/CHHE">China Health</a> Technology Group proposes HKD 51.5 million rights issue; shares offered at HKD 0.25 each
  • China Health Technology Group plans a non-underwritten rights issue of up to 205,848,440 shares, offering 2 rights shares for every 1 existing share.
  • The subscription price is HKD 0.25 per rights share, with gross proceeds of up to HKD 51.5 million.
  • Net proceeds are expected to be about HKD 50.0 million after estimated expenses of HKD 1.5 million.
  • Any unsubscribed rights shares will be placed to at least six independent investors through Tiger Faith Securities on a best-efforts basis.
  • Placing commission is set at 4% of the placing amount for shares successfully placed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Health Technology Group Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12074571), on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment